Innovating Clinical Trials appearance, Part 2

In Part 2 of this 3-part podcast with Liam Eves and Ted Trafford, we cover:

- Why I’m bullish on research site valuations

- My own experience with a company that owned both a CRO and a site

- The highlight for me was Ted’s perspective on CROs owning sites (starts around 8:15)

- Going into more detail on the problems in preclinical (timely given Charles River’s super depressing conference presentation yesterday)

- Areas of AI where I’m excited (preclinical discovery) and not so much (Microsoft Excel)